Accepted abstracts from TAT 2020 are published and open to all.
CANCELLED - ESMO Targeted Anticancer Therapies Congress 2020
- Start date
- 02 Mar 2020
- End date
- 04 Mar 2020
- Location
- Paris, France
The TAT Congress has firmly established itself as the must-attend forum for all experts focusing on early phase drug development and translational research.
Stakeholders from academia and industry meet with clinicians, researchers and regulators from all around the world to facilitate the development of new anti-cancer treatments and make more options available to patients.
The TAT Congress series has effectively transformed the landscape of early drug development and you have the opportunity to be a part of a highly influential meeting.
Programme
Access the online programme for TAT 2020 – Targeted Anticancer Therapies!
Congress Coverage
All the resources from ESMO Targeted Anticancer Therapies Congress 2020: abstracts and abstract book are available.
Congress Officers
Find out who are the TAT 2020 Congress Officers
Industry Participation
Participation information for our industry partners
Contacts
Get in touch with the organisers of ESMO Targeted Anticancer Therapies Congress 2020. Contact details here